Publication Date
7-1-2023
Journal
Advanced Healthcare Materials
DOI
10.1002/adhm.202203209
PMID
36906514
PMCID
PMC10440236
PubMedCentral® Posted Date
7-1-2024
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Humans, Europium, Contrast Media, Oxygen, Fluorocarbons, Magnetic Resonance Imaging, Hypoxia, EuII, hypoxia, MRI, perfluorocarbons
Abstract
Radiographic mapping of hypoxia is needed to study a wide range of diseases. Complexes of EuII are a promising class of molecules to fit this need, but they are generally limited by their rapid oxidation rates in vivo. Here, a perfluorocarbon-nanoemulsion perfused with N2, forms an interface with aqueous layers to hinder oxidation of a new perfluorocarbon-soluble complex of EuII. Conversion of the perfluorocarbon solution of EuII into nanoemulsions results in observable differences between reduced and oxidized forms by MRI both in vitro and in vivo. Oxidation in vivo occurrs over a period of ~30 min compared to <5 min for a comparable EuII-containing complex without nanoparticle interfaces. These results represent a critical step toward delivery of EuII-containing complexes in vivo for the study of hypoxia.
Graphical Abstract
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Medical Specialties Commons, Neurosciences Commons
Comments
Associated Data